ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,745.37
      0.40%
      US Tech 100
      19,572.00
      0.72%
      Dow Jones
      42,175.11
      0.62%
      Brent Oil
      70.575
      -0.53%
      Bitcoin
      65,157.85
      -0.04%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. New River Pharmaceuticals (MM) (NRPH) Quote

      New River Pharmaceuticals (MM)

      New River Pharmaceuticals (MM) (NRPH)

      NASDAQ
      0.00
      0.00
      (0.00%)
      Closed September 26 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      -
      Bid
      -
      Ask
      -
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      -
      Open
      -
      Last Trade
      Last Trade Time
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      NRPH Latest News

      More News

      HealthShares(TM) Announces Changes to the HealthShares(TM) Neuroscience and Composite Indices

      NEW YORK, April 18 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the...

      April 18 2007
      PR Newswire (US)

      New River Pharmaceuticals Inc. Announces Convertibility of 3.50% Convertible Subordinated Notes Due 2013

      RADFORD, Va., April 3 /PRNewswire-FirstCall/ -- New River Pharmaceuticals Inc. (NASDAQ:NRPH) today announced that, in connection with its previously disclosed pending acquisition by Shire plc...

      April 03 2007
      PR Newswire (US)

      New River Announces Expiration of Hart-Scott-Rodino Waiting Period

      RADFORD, Va., March 19 /PRNewswire-FirstCall/ -- New River Pharmaceuticals Inc. (NASDAQ:NRPH) today announced that the waiting period under the Hart- Scott-Rodino Antitrust Improvements Act of...

      March 19 2007
      PR Newswire (US)

      New River Pharmaceuticals Announces Year-End Results

      RADFORD, Va., March 13 /PRNewswire-FirstCall/ -- New River Pharmaceuticals Inc. (NASDAQ:NRPH) today announced its financial results for the year ended December 31, 2006. New River recognized a...

      March 13 2007
      PR Newswire (US)

      Shire and New River Pharmaceuticals Announce FDA Approval of the First and Only Stimulant Prodrug VYVANSE(TM) (lisdexamfetamine

      BASINGSTOKE, England, PHILADELPHIA, Pennsylvania and Radford, VIRGINIA, February 23 /PRNewswire-FirstCall/ -- Shire plc (LSE:SHPLSE:NASDAQ:LSE:SHPGYLSE: TSX:LSE:SHQ) and its collaborative...

      February 23 2007
      PR Newswire (US)

      New River Pharmaceuticals to be Acquired by Shire plc for $64 per Share

      RADFORD, Va., Feb. 20 /PRNewswire-FirstCall/ -- New River Pharmaceuticals Inc. (NASDAQ:NRPH) announced today that it has signed a definitive agreement with Shire plc...

      February 20 2007
      PR Newswire (US)

      New River Pharmaceuticals to Present at 2007 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Conference

      RADFORD, Va., Feb. 5 /PRNewswire-FirstCall/ -- New River Pharmaceuticals Inc. (NASDAQ:NRPH) announced today that it plans to present at the 2007 Merrill Lynch Global Pharmaceutical...

      February 05 2007
      PR Newswire (US)

      James Shaffer Joins New River Pharmaceuticals as Vice President, Sales and Marketing

      RADFORD, Va., Jan. 25 /PRNewswire-FirstCall/ -- New River Pharmaceuticals Inc. (NASDAQ:NRPH) announced today that James P. Shaffer has been appointed the company's Vice President, Sales and...

      January 25 2007
      PR Newswire (US)

      New River Pharmaceuticals and Shire Receive Approvable Letter for VYVANSE(TM) (lisdexamfetamine dimesylate) for the Treatment of

      Launch Expected Q2 2007 BASINGSTOKE, U.K., PHILADELPHIA and RADFORD, Va., Dec. 21 /PRNewswire-FirstCall/ -- New River Pharmaceuticals Inc. (NASDAQ:NRPH) and its collaborative partner Shire plc...

      December 21 2006
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DUOFangDD Network Group Ltd
      $ 1.05
      (110.00%)
      		257.78M
      TBIOTelesis Bio Inc
      $ 3.98
      (71.55%)
      		25.89M
      ATGLAlpha Technology Group Limited
      $ 3.68
      (71.16%)
      		14.33M
      KTTAPasithea Therapeutics Corporation
      $ 5.73
      (49.02%)
      		57.24M
      CNEYCN Energy Group Inc
      $ 0.5799
      (39.73%)
      		105.6M
      XPONExpion360 Inc
      $ 0.0631
      (-24.88%)
      		52.58M
      SMCXDefiance Daily Target 2X Long SMCI ETF
      $ 7.2601
      (-24.69%)
      		4.84M
      PGYPagaya Technologies Ltd
      $ 9.645
      (-22.53%)
      		14.01M
      DBGIDigital Brands Group Inc
      $ 0.310301
      (-22.42%)
      		822.02k
      MDXHMDxHealth SA
      $ 1.99
      (-21.65%)
      		1.61M
      NVDANVIDIA Corporation
      $ 124.04
      (0.43%)
      		302.67M
      DUOFangDD Network Group Ltd
      $ 1.05
      (110.00%)
      		257.78M
      SQQQProShares UltraPro Short QQQ
      $ 7.32
      (-2.01%)
      		160.61M
      HOLOMicroCloud Hologram Inc
      $ 0.2866
      (18.92%)
      		111.05M
      MUMicron Technology Inc
      $ 109.88
      (14.73%)
      		107.97M

      Discussion

      View Full Feed
      kund kund 43 seconds ago
      Bad news for Misleading, by the time he wakes up from his tiny trial coma, karXT will have captured 99% market.
      AVXL
      TRAPPER JIM TRAPPER JIM 46 seconds ago
      We got our driveway and sidewalks put in today. WOOHOO
      delerious1 delerious1 1 minute ago
      ...and refresh my memory....why do you care?
      RONN
      CountOfMeltedCrisco CountOfMeltedCrisco 2 minutes ago
      You're welcome; whenever you see a chart where the prices
      don't jive with what you remember, the first thought that should
      cross your mind is : "Reverse Split adjustment". There are lots
      of good sites out there that have R/S info on any stock, and all just
      a quick sear
      NBRI
      Paulie Cashews Paulie Cashews 2 minutes ago
      Correct, ma'am. Glad I'm in Manhattan because I just checked Florida on Google maps and found out why IHUB's been having problems:

      adserv.stocksite.com/images/paulie/ihhurricane.jpg

      www.investorshub.com/boards/board.asp?board_id=2581 Paulie's Pixel Palace
      shajandr shajandr 2 minutes ago
      Company name change to Louetta's Losses, Inc. Ticker remains BDGY.
      Steady_T Steady_T 3 minutes ago
      Why would they spend the money to test someone else's drug? The test is against the placebo and then the results are compared to the KarXT trial results. The FDA will look at KarXT only if it becomes the SOC.
      AVXL
      Quick Sand Quick Sand 3 minutes ago
      Yes,
      Failure is the only thing they have PROVEN to be good at.

      Although not funny for shareholders.
      QSEP
      MiamiGent MiamiGent 4 minutes ago
      Provocative post (in the non-pejorative sense)!
      NVDA
      eyeownu eyeownu 4 minutes ago
      NICE DAY
      DUO
      BefallenKnight BefallenKnight 4 minutes ago
      S1 Ain’t Gonna Mean Squat
      SEC scrutiny is the LAST thing RONN needs. Uplisting to Nasdaq is utterly laughable and now would require a massive reverse split no matter what RONN tweets.

      Fundamentally RONN is dead in the water. Always has been. This company never has and never wi
      RONN
      georgejjl georgejjl 4 minutes ago
      The FDA has approved Karuna/Bristol Myers Squibb’s KarXT (Cobenfy) — an oral dual M1/M4 muscarinic acetylcholine receptor (mAChR) agonist — for schizophrenia.

      https://www.nature.com/articles/d41573-024-00155-8

      Good luck and GOD bless,
      AVXL
      vuletini vuletini 5 minutes ago
      Not sure if you will hear from him again.... connect the dots...ding ding ding
      SHIBUSD
      stealofadeal stealofadeal 6 minutes ago
      $GEVI Ask is thin on this on and back up to .90 coming.
      GEVI
      radly radly 7 minutes ago
      2 cent texts
      IMTL
      Glenn5995 Glenn5995 8 minutes ago
      That makes sense now, because it was showing in January 2005 it was $13250.00. Thank you for the clarification.
      NBRI
      Mac1957 Mac1957 8 minutes ago
      Camden county shows no outages
      PLUG
      PENNIEStoSTACKS PENNIEStoSTACKS 9 minutes ago
      https://winnerswaygers.com/ai-wagers

      https://x.com/IDVVcorp/status/1835669743615001017
      IDVV
      Manspider Manspider 9 minutes ago
      Jesus..I hope I have enough time later in life to post that long of a post..lol All good stuff !!! :-D
      GTCH
      tiger_trader tiger_trader 9 minutes ago
      I sure hope this reverse merger after all of its catalysts hits $1 by the end of next year so I can retire!!!
      IGPK
      jour_trader jour_trader 9 minutes ago
      Just looking into opening a position. Why aren’t any of 2024 results printed? Buyback is taking place, but investors can’t see any recent financial progress to determine same outcome for themselves. I’m in early DD stage, but eager to dive in to more data and insights as time permits.
      GRRR
      stealofadeal stealofadeal 9 minutes ago
      $GEVI Time to load up on this one. Long and strong!
      GEVI
      radly radly 9 minutes ago
      How many more years are the pumpers here going to keep saying the same thing????
      WDLF

      Your Recent History

      NASDAQ
      NRPH
      New River
      Delayed Upgrade Clock